Elo Mutual Pension Insurance’s Regeneron Pharmaceuticals REGN Stock Holding History

Elo Mutual Pension Insurance’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.16M	Sell	11,849 -1,112	-9%	-$851K	0.15%	117
2025 Q4	$10M	Sell	12,961 -470	-3%	-$319K	0.15%	117
2025 Q3	$7.55M	Buy	13,431 +2,514	+23%	+$1.42M	0.12%	138
2025 Q2	$5.73M	Sell	10,917 -1,215	-10%	-$678K	0.12%	145
2025 Q1	$7.69M	Buy	+12,132	New	+$8.34M	0.17%	108
2024 Q4	–	Sell	-10,300	Closed	-$10.8M	–	535
2024 Q3	$10.8M	Buy	+10,300	New	+$11.5M	0.23%	82

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Elo Mutual Pension Insurance's REGN Position: Q1 2026 in Review

Elo Mutual Pension Insurance reduced its Regeneron Pharmaceuticals (REGN) stake by 8.6% in Q1 2026, selling an estimated $851K and leaving 11,849 shares worth $9.16M. The position accounts for 0.15% of the portfolio, ranked #117.

Elo Mutual Pension Insurance first reported a position in REGN in Q3 2024 and has held it in 6 quarters since. The position peaked at $10.8M in Q3 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Elo Mutual Pension Insurance held 11,849 shares of Regeneron Pharmaceuticals worth $9.16M as of Q1 2026.
Elo Mutual Pension Insurance sold 1,112 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $851K.
Regeneron Pharmaceuticals made up 0.15% of Elo Mutual Pension Insurance's portfolio in Q1 2026, its #117 holding.
Elo Mutual Pension Insurance first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
Elo Mutual Pension Insurance's Regeneron Pharmaceuticals position peaked at $10.8M in Q3 2024.
1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Elo Mutual Pension Insurance's 13F filing for Q1 2026, filed 11 May 2026.